Cargando…

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models

Detalles Bibliográficos
Autores principales:	Pacheco, Maria Pires, Bintener, Tamara, Sauter, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557803/ https://www.ncbi.nlm.nih.gov/pubmed/30979684 http://dx.doi.org/10.1016/j.ebiom.2019.04.017

Ejemplares similares

Towards the routine use of in silico screenings for drug discovery using metabolic modelling
por: Bintener, Tamara, et al.
Publicado: (2020)

Identifying and targeting cancer-specific metabolism with network-based drug target prediction
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma
por: Bintener, Tamara, et al.
Publicado: (2023)

Importance of the biomass formulation for cancer metabolic modeling and drug prediction
por: Moscardó García, María, et al.
Publicado: (2021)

Project-based learning course on metabolic network modelling in computational systems biology
por: Sauter, Thomas, et al.
Publicado: (2022)

Towards improved genome-scale metabolic network reconstructions: unification, transcript specificity and beyond
por: Pfau, Thomas, et al.
Publicado: (2016)

Fast Reconstruction of Compact Context-Specific Metabolic Network Models
por: Vlassis, Nikos, et al.
Publicado: (2014)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

Integrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic network
por: Pacheco, Maria Pires, et al.
Publicado: (2015)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019)

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling
por: Kishk, Ali, et al.
Publicado: (2021)

Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021)

Metabolic modeling-based drug repurposing in Glioblastoma
por: Tomi-Andrino, Claudio, et al.
Publicado: (2022)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Network-based stage-specific drug repurposing for Alzheimer’s disease
por: Savva, Kyriaki, et al.
Publicado: (2022)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

A dynamic multi-tissue model to study human metabolism
por: Martins Conde, Patricia, et al.
Publicado: (2021)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
por: Zhang, Zhen, et al.
Publicado: (2023)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs()
por: Timaner, Michael, et al.
Publicado: (2018)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

Network-based approach to prediction and population-based validation of in silico drug repurposing
por: Cheng, Feixiong, et al.
Publicado: (2018)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Repurposing long-term ecological studies for climate change
por: Jackson, Stephen T.
Publicado: (2023)

Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
por: Movia, Dania, et al.
Publicado: (2020)

Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021)

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)

Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing
por: Wang, Zichen, et al.
Publicado: (2020)

Predictive Modeling of Drug Treatment in the Area of Personalized Medicine
por: Ogilvie, Lesley A., et al.
Publicado: (2015)

Decentralize-Change-Recentralize Model of Drug Information Networks in Health Centers: Decentralized Drug Information Services
por: Thomas, Dixon, et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Structural Changes, Biological Consequences, and Repurposing of Colchicine Site Ligands
por: Montecinos, Felipe, et al.
Publicado: (2023)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021)

scFASTCORMICS: A Contextualization Algorithm to Reconstruct Metabolic Multi-Cell Population Models from Single-Cell RNAseq Data
por: Pacheco, Maria Pires, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gemkfeokk5e3kgkq6mqmudj6jv